88367 CPT® code: payer coverage and prior authorization88367 appears in 11 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross NC, BlueCross BlueShield of South Carolina, Cigna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Cervical Cancer Screening and Diagnosis (0443) | not covered (range 88367-88377) | Jul 22, 2026 | payer document |
| Aetna | Trastuzumab Products (0313) | listed, no stance (range 88367-88377) | Jun 8, 2026 | payer document |
| Aetna | Tumor Markers (0352) | listed, no stance (range 88367-88377) | Aug 25, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Urinary Biomarkers For Cancer Screening Diagnosis And Surveillance | unproven / investigational | payer document | |
| Blue Cross NC | Esophageal Pathology Testing AHS - M2171 | listed, no stance | Apr 1, 2026 | payer document |
| Blue Cross NC | Molecular Diagnostics for Breast Cancer Prognosis AHS - M2020 | listed, no stance | Apr 1, 2026 | payer document |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 88300-88399) | Mar 1, 2024 | payer document |
| BlueCross BlueShield of South Carolina | Esophageal Pathology Testing (CAM 242) Number | listed, no stance | Apr 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Laboratory/Pathology Services (CAM 472) | listed, no stance | Jan 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Molecular Diagnostics for Breast Cancer Prognosis (CAM 278) | listed, no stance | Apr 1, 2026 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.